دورية أكاديمية
أعرض في EDS

Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy.

التفاصيل البيبلوغرافية
العنوان: Extrahepatic Manifestations of Chronic HBV Infection and the Role of Antiviral Therapy.
المؤلفون: Mazzaro C; Clinical of Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy., Adinolfi LE; Unit Internal Medicine, Department of Advanced Medical and Surgery Sciences, Luigi Vanvitelli University of Campania, 80138 Naples, Italy., Pozzato G; Department of Clinical and Surgical Sciences, Maggiore Hospital University of Trieste, 34149 Trieste, Italy., Nevola R; Unit Internal Medicine, Department of Advanced Medical and Surgery Sciences, Luigi Vanvitelli University of Campania, 80138 Naples, Italy., Zanier A; Department of Internal Medicine, Pordenone General Hospital, 33170 Pordenone, Italy., Serraino D; Cancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy., Andreone P; Division of Internal Medicine, Department of Medical and Surgical Sciences, Maternal-Infantile and Adult, University of Modena and Reggio Emilia, 41124 Modena, Italy., Fenoglio R; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) CMID-Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy., Sciascia S; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) CMID-Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy., Gattei V; Clinical of Experimental Onco-Haematology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy., Roccatello D; University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITA-ERN Member) CMID-Nephrology and Dialysis Unit, San Giovanni Bosco Hub Hospital, Department of Clinical and Biological Sciences, University of Turin, 10154 Turin, Italy.
المصدر: Journal of clinical medicine [J Clin Med] 2022 Oct 23; Vol. 11 (21). Date of Electronic Publication: 2022 Oct 23.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101606588 Publication Model: Electronic Cited Medium: Print ISSN: 2077-0383 (Print) Linking ISSN: 20770383 NLM ISO Abbreviation: J Clin Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2012]-
مستخلص: The hepatitis B virus (HBV) infection leads to chronic hepatitis, cirrhosis, and hepatocarcinoma. However, about 20% of patients experience extrahepatic manifestations such as polyarteritis nodosa, non-rheumatoid arthritis, non-Hodgkin lymphoma, cryoglobulinemic vasculitis, and glomerulonephritis. These influence the patient's morbidity, quality of life and mortality. The treatment of an HBV infection is based on nucleotide analogues (NAs) which are safe and effective for the suppression of HBV-DNA in almost 100% of cases. A few studies have shown that NAs induce a viral response and an improvement of extrahepatic diseases. There is a lack of a thorough analysis of the available treatments for extrahepatic HBV manifestations. In 90% to 100% of cases, the NAs stop the HBV replication, and they produce a clinical response in the majority of patients with mild to moderate extrahepatic signs/symptoms. Arthritis can definitely disappear after the HBV elimination and, in some cases, the HBV eradication following NAs therapy appears to improve the renal function in HBV-related nephropathies. Plasma exchange can be used in subjects who are suffering from the most aggressive forms of cryoglobulinemic vasculitis and glomerulonephritis, progressive peripheral neuropathy, and life-threatening cases, and this can be combined with glucocorticosteroids and antiviral agents. In selected refractory patients, the use of rituximab in conjunction with NAs therapy can be considered. The review provides an update on extrahepatic conditions that are linked to HBV and the impact of treating HBV with NAs.
References: Am J Nephrol. 2015;41(4-5):345-53. (PMID: 26087695)
QJM. 1995 Feb;88(2):115-26. (PMID: 7704562)
Curr Rheumatol Rep. 2021 Feb 10;23(3):14. (PMID: 33569653)
Curr Opin Rheumatol. 2019 Sep;31(5):499-504. (PMID: 31090590)
Jpn J Cancer Res. 2002 May;93(5):471-7. (PMID: 12036441)
Antiviral Res. 2014 Feb;102:35-43. (PMID: 24316030)
Leuk Lymphoma. 2009 Apr;50(4):604-11. (PMID: 19373659)
Am J Pathol. 1978 Mar;90(3):619-32. (PMID: 24342)
Arthritis Rheum. 2004 Jun 15;51(3):482-7. (PMID: 15188337)
Nephrology (Carlton). 2017 Jun;22(6):449-455. (PMID: 27062412)
J Autoimmun. 2015 Dec;65:74-81. (PMID: 26320984)
Lancet Oncol. 2010 Sep;11(9):827-34. (PMID: 20688564)
Kidney Int. 2019 Feb;95(2):281-295. (PMID: 30665569)
World J Gastroenterol. 2015 Nov 14;21(42):11941-53. (PMID: 26576083)
Clin Exp Rheumatol. 2014 Mar-Apr;32(2):168-73. (PMID: 24143967)
Clin Liver Dis. 2004 May;8(2):403-18. (PMID: 15481347)
Eur J Haematol. 2020 May;104(5):469-475. (PMID: 31961011)
Kidney Int Suppl. 1991 Dec;35:S40-5. (PMID: 1770709)
Am J Pathol. 1994 Nov;145(5):1001-7. (PMID: 7977632)
Rheum Dis Clin North Am. 2009 Feb;35(1):125-37. (PMID: 19481001)
Ann Rheum Dis. 1994 May;53(5):334-7. (PMID: 7912504)
World J Gastroenterol. 2015 Jan 7;21(1):283-91. (PMID: 25574103)
Clin Rev Allergy Immunol. 2008 Feb;34(1):111-7. (PMID: 18270864)
J Med Virol. 1994 Dec;44(4):330-5. (PMID: 7897364)
Nat Rev Dis Primers. 2018 Aug 2;4(1):11. (PMID: 30072738)
J Rheumatol. 2009 Apr;36(4):712-6. (PMID: 19286846)
Viruses. 2021 May 30;13(6):. (PMID: 34070832)
Ann Hematol. 2008 Jun;87(6):475-80. (PMID: 18327583)
Clin Nephrol. 2012 Dec;78(6):456-64. (PMID: 23164414)
Ann Intern Med. 1977 Sep;87(3):287-92. (PMID: 900672)
Vaccine. 2018 Sep 11;36(38):5796-5802. (PMID: 30100071)
Infect Agent Cancer. 2016 Jun 23;11:27. (PMID: 27340429)
Haematologica. 2006 Apr;91(4):554-7. (PMID: 16585021)
Adv Chronic Kidney Dis. 2015 Sep;22(5):343-51. (PMID: 26311595)
N Engl J Med. 2021 Mar 18;384(11):1038-1052. (PMID: 33730456)
Gastroenterol Hepatol (N Y). 2013 Feb;9(2):123-6. (PMID: 23983659)
Sci Rep. 2021 Sep 15;11(1):18407. (PMID: 34526634)
J Autoimmun. 2001 May;16(3):269-74. (PMID: 11334492)
Diseases. 2018 May 03;6(2):. (PMID: 29751499)
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1529-1533. (PMID: 27797900)
Eur J Haematol. 2007 Aug;79(2):132-7. (PMID: 17635237)
Cleve Clin J Med. 2002;69 Suppl 2:SII20-3. (PMID: 12086259)
Blood. 2011 Feb 10;117(6):1792-8. (PMID: 20959600)
Am J Med. 1966 Jun;40(6):828-36. (PMID: 4956870)
J Viral Hepat. 2018 Aug;25(8):894-903. (PMID: 29532605)
Vaccine. 2012 Mar 9;30(12):2212-9. (PMID: 22273662)
Am J Med. 1974 Nov;57(5):775-88. (PMID: 4216269)
J Infect. 2020 Feb;80(2):219-224. (PMID: 31846632)
Medicine (Baltimore). 2005 Sep;84(5):313-322. (PMID: 16148731)
Semin Arthritis Rheum. 2004 Jun;33(6):355-74. (PMID: 15190522)
J Viral Hepat. 2015 Oct;22(10):828-34. (PMID: 25650146)
Hepatology. 2001 Jul;34(1):194-203. (PMID: 11431751)
Acta Clin Belg. 2015 Aug;70(4):301-3. (PMID: 25977147)
Am J Med. 1977 May;62(5):783-91. (PMID: 16490)
J Hepatol. 2005 Nov;43(5):764-70. (PMID: 16087273)
Arthritis Rheum. 2010 Feb;62(2):616-26. (PMID: 20112401)
Oncogene. 2010 Apr 22;29(16):2309-24. (PMID: 20228847)
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):208-14. (PMID: 21098651)
J Rheumatol. 1996 Sep;23(9):1641-3. (PMID: 8877939)
Hepatology. 2015 Apr;61(4):1145-53. (PMID: 25431357)
PLoS One. 2020 Jan 15;15(1):e0227532. (PMID: 31940324)
Gastroenterology. 1975 Dec;69(6):1286-91. (PMID: 1193327)
J Clin Microbiol. 2017 Oct;55(10):2972-2982. (PMID: 28747369)
Medicine (Baltimore). 1995 Sep;74(5):238-53. (PMID: 7565065)
Autoimmun Rev. 2019 Aug;18(8):778-785. (PMID: 31181326)
Nephron Clin Pract. 2011;119(1):c41-9; discussion c49. (PMID: 21677438)
J Viral Hepat. 2016 Jul;23(7):545-59. (PMID: 27028545)
Am J Med. 2015 Sep;128(9):950-5. (PMID: 25837517)
Int J Cancer. 2020 Dec 1;147(11):3075-3084. (PMID: 32478856)
Pathol Biol (Paris). 1999 Mar;47(3):237-44. (PMID: 10214615)
N Engl J Med. 2004 Mar 11;350(11):1118-29. (PMID: 15014185)
Autoimmun Rev. 2020 Aug;19(8):102589. (PMID: 32540448)
J Hepatol. 2017 Aug;67(2):370-398. (PMID: 28427875)
Dig Liver Dis. 2016 Jul;48(7):780-4. (PMID: 27106525)
BMC Nephrol. 2020 Sep 14;21(1):395. (PMID: 32928133)
فهرسة مساهمة: Keywords: HBV extra-hepatic manifestations; HBV-related cryoglobulinemia; HBV-related glomerulonephritis; HBV-related vasculitis; entecavir; hepatitis B virus; tenofovir
تواريخ الأحداث: Date Created: 20221111 Latest Revision: 20221117
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9657147
DOI: 10.3390/jcm11216247
PMID: 36362478
قاعدة البيانات: MEDLINE
الوصف
تدمد:2077-0383
DOI:10.3390/jcm11216247